Debt-to-equity of CHINA PHARMA HOLDINGS, INC. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
CHINA PHARMA HOLDINGS, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • CHINA PHARMA HOLDINGS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 99%.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

CHINA PHARMA HOLDINGS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 99% 30 Sep 2025
Q2 2025 103% 30 Jun 2025
Q1 2025 98% 31 Mar 2025
Q4 2023 187% -155% -45% 31 Dec 2023
Q3 2023 241% -86% -26% 30 Sep 2023
Q2 2023 315% +56% +22% 30 Jun 2023
Q1 2023 338% +107% +46% 31 Mar 2023
Q4 2022 342% +139% +68% 31 Dec 2022
Q3 2022 327% +150% +85% 30 Sep 2022
Q2 2022 259% +81% +46% 30 Jun 2022
Q1 2022 231% +59% +35% 31 Mar 2022
Q4 2021 204% +34% +20% 31 Dec 2021
Q3 2021 177% +14% +8.9% 30 Sep 2021
Q2 2021 178% +76% +74% 30 Jun 2021
Q1 2021 171% +99% +136% 31 Mar 2021
Q4 2020 169% +113% +200% 31 Dec 2020
Q3 2020 163% +114% +238% 30 Sep 2020
Q2 2020 102% +56% +121% 30 Jun 2020
Q1 2020 73% +28% +63% 31 Mar 2020
Q4 2019 56% +14% +33% 31 Dec 2019
Q3 2019 48% +8% +20% 30 Sep 2019
Q2 2019 46% +8.5% +23% 30 Jun 2019
Q1 2019 44% +8.5% +24% 31 Mar 2019
Q4 2018 42% +7.9% +23% 31 Dec 2018
Q3 2018 40% +6.8% +20% 30 Sep 2018
Q2 2018 38% +3.4% +10% 30 Jun 2018
Q1 2018 36% +1.1% +3.2% 31 Mar 2018
Q4 2017 35% -0.71% -2% 31 Dec 2017
Q3 2017 33% -1.7% -4.8% 30 Sep 2017
Q2 2017 34% -1% -2.9% 30 Jun 2017
Q1 2017 35% +0.67% +2% 31 Mar 2017
Q4 2016 35% +1.6% +4.8% 31 Dec 2016
Q3 2016 35% +2.1% +6.3% 30 Sep 2016
Q2 2016 35% +5.8% +20% 30 Jun 2016
Q1 2016 34% +8% +31% 31 Mar 2016
Q4 2015 34% +11% +48% 31 Dec 2015
Q3 2015 33% +13% +63% 30 Sep 2015
Q2 2015 29% +12% +64% 30 Jun 2015
Q1 2015 26% +11% +71% 31 Mar 2015
Q4 2014 23% +10% +80% 31 Dec 2014
Q3 2014 20% +9.6% +90% 30 Sep 2014
Q2 2014 18% +7.9% +79% 30 Jun 2014
Q1 2014 15% +5% +48% 31 Mar 2014
Q4 2013 13% +1.6% +14% 31 Dec 2013
Q3 2013 11% -0.44% -4% 30 Sep 2013
Q2 2013 10% -0.69% -6.5% 30 Jun 2013
Q1 2013 10% +0.04% +0.39% 31 Mar 2013
Q4 2012 11% 31 Dec 2012
Q3 2012 11% 30 Sep 2012
Q2 2012 11% 30 Jun 2012
Q1 2012 10% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.